IDEAYA Biosciences (IDYA) Retained Earnings (2018 - 2026)

IDEAYA Biosciences has reported Retained Earnings for 9 years, with the latest figure at -$835.1 million in Q1 2026.

• Quarterly Retained Earnings fell 52787.7% year-over-year to -$835.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$835.1 million (down 52787.7% YoY) and the FY2025 annual result came in at -$736.5 million, down 18.25% from the prior year.
• Retained Earnings retreated to -$835.1 million in Q1 2026 per IDYA's latest filing, from -$736.5 million in the prior quarter.
• Over five years, Retained Earnings peaked at $1.6 million in Q1 2025 and troughed at -$835.1 million in Q1 2026.
• A 5-year average of -$283.7 million and a median of -$259.0 million in 2023 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 65570.53% in 2024, then jumped 207.42% in 2025.
• Over 5 years, Retained Earnings stood at -$2.9 million in 2022, then plunged by 12033.89% to -$348.4 million in 2023, then tumbled by 78.79% to -$622.8 million in 2024, then declined by 18.25% to -$736.5 million in 2025, then dropped by 13.38% to -$835.1 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$835.1 million, -$736.5 million, and -$653.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.